LSU Health Shreveport chooses Digital Science to support Research Discovery and Integrity (opens in new window/tab)
March Biosciences and Cancer Focus Fund Announce $4.8 Million Investment to Support a Phase 2 Clinical Trial of Novel CAR-T Therapy for T-Cell Lymphoma (opens in new window/tab)
Dr. Matthew Woolard awarded a 4-year ROI grant by the NIH's National Heart, Lung and Blood Institute & National Institute of General Medical Sciences
The names for COVID variants are a confusing alphabet soup. Here’s why it got so muddled. (opens in new window/tab)